Literature DB >> 18264981

Energy metabolism transition in multi-cellular human tumor spheroids.

Sara Rodríguez-Enríquez1, Juan Carlos Gallardo-Pérez, Alejandro Avilés-Salas, Alvaro Marín-Hernández, Liliana Carreño-Fuentes, Vilma Maldonado-Lagunas, Rafael Moreno-Sánchez.   

Abstract

It is thought that glycolysis is the predominant energy pathway in cancer, particularly in solid and poorly vascularized tumors where hypoxic regions develop. To evaluate whether glycolysis does effectively predominate for ATP supply and to identify the underlying biochemical mechanisms, the glycolytic and oxidative phosphorylation (OxPhos) fluxes, ATP/ADP ratio, phosphorylation potential, and expression and activity of relevant energy metabolism enzymes were determined in multi-cellular tumor spheroids, as a model of human solid tumors. In HeLa and Hek293 young-spheroids, the OxPhos flux and cytochrome c oxidase protein content and activity were similar to those observed in monolayer cultured cells, whereas the glycolytic flux increased two- to fourfold; the contribution of OxPhos to ATP supply was 60%. In contrast, in old-spheroids, OxPhos, ATP content, ATP/ADP ratio, and phosphorylation potential diminished 50-70%, as well as the activity (88%) and content (3 times) of cytochrome c oxidase. Glycolysis and hexokinase increased significantly (both, 4 times); consequently glycolysis was the predominant pathway for ATP supply (80%). These changes were associated with an increase (3.3 times) in the HIF-1alpha content. After chronic exposure, both oxidative and glycolytic inhibitors blocked spheroid growth, although the glycolytic inhibitors, 2-deoxyglucose and gossypol (IC(50) of 15-17 nM), were more potent than the mitochondrial inhibitors, casiopeina II-gly, laherradurin, and rhodamine 123 (IC(50) > 100 nM). These results suggest that glycolysis and OxPhos might be considered as metabolic targets to diminish cellular proliferation in poorly vascularized, hypoxic solid tumors. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18264981     DOI: 10.1002/jcp.21392

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  42 in total

Review 1.  Metabolic genes in cancer: their roles in tumor progression and clinical implications.

Authors:  Eiji Furuta; Hiroshi Okuda; Aya Kobayashi; Kounosuke Watabe
Journal:  Biochim Biophys Acta       Date:  2010-02-01

2.  On the properties of calcium-induced permeability transition in neonatal heart mitochondria.

Authors:  Natalia Pavón; Juan Carlos Gallardo; Luz María Hernández-Esquivel; Mohammed El-Hafidi; Mabel Buelna-Chontal; Cecilia Zazueta; Sara Rodríguez-Enríquez; Edmundo Chávez
Journal:  J Bioenerg Biomembr       Date:  2011-11-23       Impact factor: 2.945

3.  The metabolic interaction of cancer cells and fibroblasts - coupling between NAD(P)H and FAD, intracellular pH and hydrogen peroxide.

Authors:  Irina N Druzhkova; Marina V Shirmanova; Maria M Lukina; Varvara V Dudenkova; Nataliya M Mishina; Elena V Zagaynova
Journal:  Cell Cycle       Date:  2016-05-02       Impact factor: 4.534

Review 4.  The Warburg effect revisited--lesson from the Sertoli cell.

Authors:  Pedro F Oliveira; Ana D Martins; Ana C Moreira; C Yan Cheng; Marco G Alves
Journal:  Med Res Rev       Date:  2014-07-12       Impact factor: 12.944

5.  Continuously perfused microbubble array for 3D tumor spheroid model.

Authors:  Sivaprakash Agastin; Ut-Binh T Giang; Yue Geng; Lisa A Delouise; Michael R King
Journal:  Biomicrofluidics       Date:  2011-06-03       Impact factor: 2.800

6.  A bioenergetic profile of non-transformed fibroblasts uncovers a link between death-resistance and enhanced spare respiratory capacity.

Authors:  Kristen P Nickens; Jakob D Wikstrom; Orian S Shirihai; Steven R Patierno; Susan Ceryak
Journal:  Mitochondrion       Date:  2013-09-27       Impact factor: 4.160

7.  Compressive stress inhibits proliferation in tumor spheroids through a volume limitation.

Authors:  Morgan Delarue; Fabien Montel; Danijela Vignjevic; Jacques Prost; Jean-François Joanny; Giovanni Cappello
Journal:  Biophys J       Date:  2014-10-21       Impact factor: 4.033

Review 8.  3D tissue-engineered model of Ewing's sarcoma.

Authors:  Salah-Eddine Lamhamedi-Cherradi; Marco Santoro; Vandhana Ramammoorthy; Brian A Menegaz; Geoffrey Bartholomeusz; Lakesla R Iles; Hesham M Amin; J Andrew Livingston; Antonios G Mikos; Joseph A Ludwig
Journal:  Adv Drug Deliv Rev       Date:  2014-08-07       Impact factor: 15.470

9.  Spheroid model study comparing the biocompatibility of Biodentine and MTA.

Authors:  Matthieu Pérard; Justine Le Clerc; Tanguy Watrin; Fleur Meary; Fabienne Pérez; Sylvie Tricot-Doleux; Pascal Pellen-Mussi
Journal:  J Mater Sci Mater Med       Date:  2013-03-21       Impact factor: 3.896

Review 10.  State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.

Authors:  Natalie Alépée; Anthony Bahinski; Mardas Daneshian; Bart De Wever; Ellen Fritsche; Alan Goldberg; Jan Hansmann; Thomas Hartung; John Haycock; Helena Hogberg; Lisa Hoelting; Jens M Kelm; Suzanne Kadereit; Emily McVey; Robert Landsiedel; Marcel Leist; Marc Lübberstedt; Fozia Noor; Christian Pellevoisin; Dirk Petersohn; Uwe Pfannenbecker; Kerstin Reisinger; Tzutzuy Ramirez; Barbara Rothen-Rutishauser; Monika Schäfer-Korting; Katrin Zeilinger; Marie-Gabriele Zurich
Journal:  ALTEX       Date:  2014-07-14       Impact factor: 6.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.